Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights From the Department of Veterans Affairs

Salim S. Virani; Julia M. Akeroyd; Vijay Nambi; Erin D. Michos; Pamela B. Morris; Khurram Nasir; Sidney C. Smith; Neil J. Stone; Laura A. Petersen; Christie M. Ballantyne

doi:10.1161/CIRCULATIONAHA.118.034993

Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights From the Department of Veterans Affairs

Salim S. Virani^*, Julia M. Akeroyd, Vijay Nambi, Erin D. Michos, Pamela B. Morris, Khurram Nasir, Sidney C. Smith, Neil J. Stone, Laura A. Petersen, Christie M. Ballantyne

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Letter

7 Scopus citations

Original language	English (US)
Pages (from-to)	410-412
Number of pages	3
Journal	Circulation
Volume	139
Issue number	3
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.118.034993
State	Published - Jan 15 2019

Keywords

cholesterol
clinical trial

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.118.034993

Cite this

Virani, S. S., Akeroyd, J. M., Nambi, V., Michos, E. D., Morris, P. B., Nasir, K., Smith, S. C., Stone, N. J., Petersen, L. A., & Ballantyne, C. M. (2019). Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights From the Department of Veterans Affairs. Circulation, 139(3), 410-412. https://doi.org/10.1161/CIRCULATIONAHA.118.034993

Virani, Salim S. ; Akeroyd, Julia M. ; Nambi, Vijay ; Michos, Erin D. ; Morris, Pamela B. ; Nasir, Khurram ; Smith, Sidney C. ; Stone, Neil J. ; Petersen, Laura A. ; Ballantyne, Christie M. / Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial : Insights From the Department of Veterans Affairs. In: Circulation. 2019 ; Vol. 139, No. 3. pp. 410-412.

@article{ece5249b61f646eb8b722bdbf701883a,

title = "Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights From the Department of Veterans Affairs",

keywords = "cholesterol, clinical trial",

author = "Virani, {Salim S.} and Akeroyd, {Julia M.} and Vijay Nambi and Michos, {Erin D.} and Morris, {Pamela B.} and Khurram Nasir and Smith, {Sidney C.} and Stone, {Neil J.} and Petersen, {Laura A.} and Ballantyne, {Christie M.}",

year = "2019",

month = jan,

day = "15",

doi = "10.1161/CIRCULATIONAHA.118.034993",

language = "English (US)",

volume = "139",

pages = "410--412",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

Virani, SS, Akeroyd, JM, Nambi, V, Michos, ED, Morris, PB, Nasir, K, Smith, SC, Stone, NJ, Petersen, LA & Ballantyne, CM 2019, 'Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights From the Department of Veterans Affairs', Circulation, vol. 139, no. 3, pp. 410-412. https://doi.org/10.1161/CIRCULATIONAHA.118.034993

Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial : Insights From the Department of Veterans Affairs. / Virani, Salim S.; Akeroyd, Julia M.; Nambi, Vijay; Michos, Erin D.; Morris, Pamela B.; Nasir, Khurram; Smith, Sidney C.; Stone, Neil J.; Petersen, Laura A.; Ballantyne, Christie M.

In: Circulation, Vol. 139, No. 3, 15.01.2019, p. 410-412.

Research output: Contribution to journal › Letter

TY - JOUR

T1 - Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial

T2 - Insights From the Department of Veterans Affairs

AU - Virani, Salim S.

AU - Akeroyd, Julia M.

AU - Nambi, Vijay

AU - Michos, Erin D.

AU - Morris, Pamela B.

AU - Nasir, Khurram

AU - Smith, Sidney C.

AU - Stone, Neil J.

AU - Petersen, Laura A.

AU - Ballantyne, Christie M.

PY - 2019/1/15

Y1 - 2019/1/15

KW - cholesterol

KW - clinical trial

UR - http://www.scopus.com/inward/record.url?scp=85060035929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060035929&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.118.034993

DO - 10.1161/CIRCULATIONAHA.118.034993

M3 - Letter

C2 - 30586689

AN - SCOPUS:85060035929

VL - 139

SP - 410

EP - 412

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 3

ER -